Literature DB >> 1684508

Immune mechanisms in bacterial and parasitic diseases: protective immunity versus pathology.

G E Grau1, R L Modlin.   

Abstract

The immunological mechanisms that contribute to resistance versus susceptibility to bacterial and parasitic infection are central to the development of improved prophylactic and therapeutic strategies. The delineation of two subsets of CD4+ T cells in the mouse that regulate these responses has provided a tremendous advance in understanding disease pathogenesis. The elucidation of protective immune mechanisms distinct from those that cause tissue damage should lead to the development of appropriate vaccines against these devastating illnesses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684508     DOI: 10.1016/0952-7915(91)90007-n

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  8 in total

1.  Gamma interferon modifies CD4+ subset expression in murine candidiasis.

Authors:  L Romani; E Cenci; A Mencacci; R Spaccapelo; U Grohmann; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Interleukin-10 modulates susceptibility in experimental cerebral malaria.

Authors:  S Kossodo; C Monso; P Juillard; T Velu; M Goldman; G E Grau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

3.  CD4 T cells and major histocompatibility complex class II expression influence worm expulsion and increased intestinal muscle contraction during Trichinella spiralis infection.

Authors:  B A Vallance; F Galeazzi; S M Collins; D P Snider
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor.

Authors:  A K Stalder; M J Carson; A Pagenstecher; V C Asensio; C Kincaid; M Benedict; H C Powell; E Masliah; I L Campbell
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Thalidomide inhibits the replication of human immunodeficiency virus type 1.

Authors:  S Makonkawkeyoon; R N Limson-Pobre; A L Moreira; V Schauf; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease.

Authors:  R Riganò; E Profumo; S Ioppolo; S Notargiacomo; E Ortona; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites.

Authors:  L M Kumaratilake; A Ferrante; T Jaeger; C M Rzepczyk
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients.

Authors:  R Riganò; E Profumo; G Di Felice; E Ortona; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.